investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Nuclear Architecture and Disease

Tom Misteli

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Stephan Mathas

Charité

Berlin, Germany

Angus Lamond

University of Dundee

Dundee, United Kingdom

Tom Misteli

National Cancer Institute (NIH)

Rockville, United States

Related projects

Shawn B Bratton

Degradation mechanisms for inhibitor of apoptosis proteins and their antagonists

All cancers but non-melanoma skin cancer

Emily Casey

Mechanisms of Action of a TCR-like mAb Directed Against WT1

All cancers but non-melanoma skin cancer

Edward Seto

The Basic and Translational Implication of SIRT1 and DNMT1 in Cancer

All cancers but non-melanoma skin cancer

Marc Nicklaus

Fundamentals of Ligand-Protein Interactions

All cancers but non-melanoma skin cancer

Paul M Thompson

ENIGMA Center for Worldwide Medicine, Imaging & Genomics

All cancers but non-melanoma skin cancer

Bhagavatula Moorthy

Molecular mechanism of cytochrome P4501A1 expression.

All cancers but non-melanoma skin cancer

Jonathan A. Cooper

Chromosome Metabolism and Cancer

All cancers but non-melanoma skin cancer

Hanlee Ji

Oligonucleotide-Selective Sequencing for integrated and rapid cancer genome analy

All cancers but non-melanoma skin cancer

Pathology

Sharon Y. R. Dent

Defining USP22 Functions During Mammalian Development

All cancers but non-melanoma skin cancer